On the 24th July 2007 breast tissue. Drugs Advisory Committee recommends approval of Evista to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in women at high risk for breast cancer.

‘Today’s action provides an important new option for women at increased risk for breast cancer,’said Steven Galson, Director, FDA Center for Drug Evaluation and Research. ‘Because Evista can cause serious side effects, should the benefits and risks of taking Evista be carefully evaluated for each individual woman. Women should talk with their doctors about whether the drug is right for them. ‘.Treating someone with depression – either via medication or psychotherapy – lead to a drop in attempted suicides, to a recent report.


Other Posts From Category "nurse":

Related Posts